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Bacterial microcompartments (BMCs) represent proteinaceous macromolecular 
nano-bioreactors that are found in a broad range of bacteria, and which are 
associated with either anabolic or catabolic processes. They consist of a semi-
permeable outer shell that packages a central metabolic enzyme or pathway, 
providing both enhanced flux and protection against toxic intermediates. 
Recombinant production of BMCs has led to their repurposing with the incorporation 
of altogether new pathways. Deconstruction of BMCs into their component parts has 
shown that some individual shell proteins self-associate into filaments that can be 
further modified into a cytoplasmic scaffold to which enzymes/proteins can be 
targeted. BMCs therefore represent a modular system that is highly suited for the 











Bacterial microcompartment structure and function. 
One of the defining differences between prokaryotes and eukaryotes is the presence 
of specific organelles and subcellular structures in the cytoplasm of the latter [1]. The 
advantages of compartmentalisation are multiple and include an ability to provide a 
physical barrier for part of the cell allowing separation from the cytoplasmic milieu, 
the generation of a microenvironment to suit specific biochemical processes and an 
intracellular location to which material can be addressed. It is therefore often quite a 
surprise for many to learn that a broad range of bacteria also have specialised 
cytoplasmic structures or organelles (Figure 1), the most common of which are called 
bacterial microcompartments (BMCs) (see Glossary) [2-4]. Although BMCs are not 
lipid-bound they are, however, surrounded by a semi-permeable proteinaceous shell 
to generate polygonal structures that encase a specific metabolic process [5]. The 
genetic software encoding these large macromolecular structures is often found 
arranged in a modular fashion within operons. This not only assists in their 
identification through data mining but this information can also be used to help 
develop and adapt these bioreactors in a plug and play fashion for useful purposes. 
 
There are two basic types of BMCs reflecting their participation in anabolic or 
catabolic processes, which are termed carboxysomes and metabolosomes 
respectively (Figure 1) [2]. The anabolic carboxysomes are involved in carbon 
fixation, utilising an encapsulated carbonic anhydrase and ribulose 1,5-bisphosphate 
carboxylase/oxygenase (RuBisCO) (Figure 1) [6, 7]. Carboxysomes are divided into 
two distinct classes that are named according to the form of encapsulated RuBisCO, 
with α-carboxysomes containing 1A RuBisCO and β-carboxysomes containing 1B 
RuBisCO. Whilst these subtypes share functionality, they vary in their structural 
components and mode of assembly (discussed below). The catabolic 
metabolosomes are often associated with the breakdown of mucosal-derived 
metabolites such as fucose, propanediol, choline and ethanolamine and contain 
multistep pathways that involve the conversion of the metabolite into an aldehyde by 
a signature enzyme and its subsequent disproportionation into an alcohol and acid 
(Figure 1) [2]. In this respect metabolosomes display much greater diversity 
comprising 27 of the 30 recently discovered BMC loci [8]. The best studied 
metabolosome is the propanediol utilisation (Pdu) system [9], although a number of 
other BMCs have also been characterised including those associated with 
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ethanolamine, ethanol and choline utilisation as well as rhamnose and fucose 
degradation [10-13]. Many metabolosomes appear to have the capability to acquire 
and recycle cofactors internally, including ATP, NAD+, CoA, adenosylcobalamin and 
S-adenosylmethionine [8, 14]. The most recent bioinformatics approach undertaken 
on BMCs has revealed the presence of 23 distinct BMC types with 30 distinct loci 
across 23 bacterial phyla, with both anabolic and catabolic functionality [8]. These 
can be separated into 8 main subtypes many of which remain experimentally 
uncharacterised. 
 
The best way to visualise BMCs is by transmission electron microscopy (TEM), 
where they are generally observed to have a size of between 100-200 nm in 
diameter, although smaller and larger versions have also been observed. 
Carboxysomes are more often reported to have an icosahedral appearance whereas 
metabolosomes are generally seen with a less regular shape. There are two main 
trains of thought as to why bacteria require these elaborate structures. The first 
centres around the idea that the compartment, with its high internal concentration of 
enzymes, enhances metabolic flux utilising proximity and channelling effects [15], 
thereby providing a competitive growth advantage over other organisms [15-17]. The 
second theory revolves around the idea that the compartment, and specifically its 
outer shell, provides a diffusion barrier for toxic or volatile intermediates such as 
aldehydes or CO2 [12, 18]. The likelihood is that it is a combination of both that has 
led to their successful integration across a broad range of bacterial species.  
 
BMCs are composed of an outer shell that is itself largely comprised of hexagonal-
shaped tiles with a central pore (Figure 2). These hexagonal tiles represent the 
facets of the structure and are generated from a number of different shell proteins 
that all share a common protein topology. There are two broad types of hexagonal 
tiles, those that are composed of six identical subunits, and which are referred to as 
BMC-H shell proteins, and those that are composed of a trimeric (pseudohexameric) 
arrangement made from three identical subunits (BMC-T shell proteins) (Figure 2). 
BMC-H proteins contain a single BMC-domain (Pfam: PF00936), whereas BMC-T 
proteins contain two fused PF00936 domains [19-22]. To form a closed structure the 
vertices of the microcompartment are capped using a pentagonal-shaped tile 
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composed of a homo-pentameric shell protein (BMC-P), with each subunit containing 
a single PF03319 domain [23-25].  
 
As the various proteins of BMCs are often encoded within operons it is possible to 
predict and prove experimentally which shell proteins are integrated into BMCs. For 
instance, with the a-carboxysome the compartment is composed of a number of 
different hexagonal tiles that are derived from 4 different BMC-H class of shell protein 
(CsoS1A-C) and a BMC-T shell protein (CsoS1D) with the BMC-P pentagonal tile 
provided by CsoS4. Similarly, for the Pdu metabolosome the shell is derived from 4 
different BMC-H components (PduA, J, K, U), two different BMC-T components 
(PduB, T) and a BMC-P in the form of PduN. 
 
BMC shell protein classes 
However, within the BMC-H and BMC-T classes there is further variation, suggesting 
optimisation of different BMCs for their specific function (Figure 2). This increasing 
diversity has led us to expand the classification system to reflect the assortment of 
shell proteins that are observed. For the BMC-H class, we propose that they are sub-
grouped into BMC-HC, BMC-HP, BMC-HEx and BMC-HFe. As highlighted in Figure 2, 
BMC-HC refers to canonical BMC-H proteins such as PduA or CsoS1 that contain a 
charged pore at the symmetry axis, and can be found in the majority of BMC systems 
[8]. These pores range from ~4 to ~7 Å in diameter and vary in charge depending on 
function [26-28]. 
 
BMC-HP includes BMC-H proteins where the BMC domain is circularly permuted, 
allowing for a similar tertiary structure using an alternative arrangement of secondary 
structure elements as exemplified with PduU (Figure 2) [29]. Such proteins 
sometimes have an N-terminal extension that forms a β-barrel structure [29, 30] that 
sits over the pore, presumably occluding the pore and preventing metabolite 
transport. BMC-HEx refers to another family of BMC-H proteins that contain C-
terminal extensions of unknown function [8]. Finally, BMC-HFe covers a fourth family 
of specialised BMC-H proteins that contain an Fe-S cluster, which is thought to play a 
role in electron transfer, or transport of intact metal clusters across the shell (Figure 




As with the BMC-H shell proteins the BMC-T class can be further divided into three 
families. Single layered BMC-T (BMC-TS) proteins such as PduB and EtuB also 
contain pores similar to their hexameric counterparts, however, evidence suggests 
that these are gated with the complexes adopting alternative conformations allowing 
diffusion of substrates in/out of the BMC lumen (Figure 2) [11, 20, 22, 28]. The pores 
are larger than those found in BMC-H complexes (~12 Å) and are predicted to allow 
larger molecules to diffuse in/out of the lumen of the BMC [22, 28]. A second family 
of BMC-T proteins (BMC-TD) contain two permuted BMC domains and form a 
stacked dimer of trimers with an enclosed central space which is likely accessed via 
gated pores [19, 20]. These larger pores (~14 Å) are suggested to provide access of 
substrates to the lumen without compromising the integrity of the shell by forming an 
airlock-like structure (Figure 2) [19, 20]. The third BMC-T family (BMC-TFe) contains 
an iron sulphur centre which occludes the pore, and has been suggested to be 
involved in processes such as electron transfer, redox sensing or regeneration of iron 
sulphur clusters of proteins within the lumen of the BMC (Figure 2) [21, 32].  
 
As mentioned previously, BMC-P proteins form pentamers that occupy the vertices of 
the BMC to mould a fully closed system (Figure 2) [24, 33, 34]. It has also been 
suggested that they aid with curvature of the shell [34]. Currently no specialised 
BMC-P shell proteins have been described, however, as some BMC systems contain 
multiple paralogues of BMC-P proteins within the same BMC operon, e.g. Haliangium 
ochraceum contains genes encoding two BMC-P proteins [8], there may be 
variations within this class that are yet to be discovered. 
 
 
BMC encapsulation/targeting peptides 
Whilst small molecules can enter the lumen of BMCs via the pores found within shell 
proteins, internalisation of proteins is thought to occur by a different process. The 
main method for incorporation of proteins into BMCs is through the use of 
encapsulation peptides (EPs). EPs have been found to be involved in all 
experimentally characterised BMCs, with the exception of the α-carboxysome family. 
Many BMCs contain multiple proteins with EPs [35-37]. EPs are located on the N- or 
C-terminus of encapsulated proteins. They are ~15-20 amino acids in length and 
form an amphipathic helix that interacts with shell proteins via a common 
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hydrophobic motif [37-39]. Some EPs interact with certain shell proteins whereas 
others may have multiple interactions within the BMC. For example, PduP contains 
an 18 amino acid EP and has been shown to interact with PduA, PduJ and PduK [36, 
39]. Conversely, EPs on EutC and EutE from the ethanolamine utilising BMC have 
been shown to specifically interact only with the EutS shell protein [40]. EPs have 
been shown to interact with specific short helical regions on shell proteins. For 
example PduP18 binds to the C-terminal helix of PduA [36] and EutC19 binds to an 
equivalent helix in EutS [40]. EPs have also been shown to cause protein 
aggregation, suggesting they may be involved in forming a condensed protein core 
[14, 41].  
 
However, not all proteins are localised to BMCs using EPs. For example, α-
carboxysomes rely on alternative protein-protein interactions to scaffold RuBisCO to 
the shell proteins using the protein CsoS2 [42]. This protein contains regions of 




BMCs appear to be self-assembling entities. Insights into the construction of both α- 
and β-carboxysomes have been gained experimentally, however, formation of 
metabolosomes remains a largely unknown process. CsoS2 is an essential 
component of α-carboxysomes, with the full-length protein containing an N-terminal 
domain that recruits shell proteins, a middle domain (M-domain) that tethers 
RuBisCO units within the lumen of the carboxysome and a C-terminal domain that 
anchors the scaffold to the growing shell [42] . Utilising CsoS2 as a scaffold, the 
proteinaceous core and the shell assemble concomitantly. Despite their shared 
function, β-carboxysomes assemble through a different mechanism. Initially, an 
aggregate is formed between RuBisCO and several conserved β-carboxysome 
proteins called CcmM and CcmN. This complex then pulls in several other 
components as well as shell proteins to initiate the encapsulation process to allow a 
pre-carboxysome to bud off from the main aggregate [37, 43].  
 
Formation of metabolosomes is suggested to occur in a similar manner to that of β-
carboxysomes. However, since ‘empty’ Pdu BMCs can be formed recombinantly 
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from the shell proteins alone [44], there must be a high degree of self-assembly in 




The synthetic biology era has developed the idea of constructing internal factories 
inside bacteria and BMCs have long been thought to provide a platform for such an 
engineering challenge. The first example of the recombinant expression of BMCs 
was achieved in 2008 and involved the transfer of the entire Pdu operon from C. 
freundii and its expression in E. coli (Figure 3A) [32]. The resulting strains were able 
to utilize propanediol and when examined, after embedding and thin sectioning, by 
TEM BMC structures were observed. Similarly, the transfer of the a-carboxysome 
operon from H. neapolitanus to E. coli resulted in the appearance of icosahedral 
structures inside the host that were shown to have CO2 fixation activity and resemble 
the wild type organelle [45]. More recently, the same a-carboxysome operon has 
been successfully transferred to the gram-positive organism C. glutamicum [46]. It 
has been proposed that the transfer of the CO2 concentrating mechanism (CCM) 
from cyanobacteria to plants has the potential to not only increase global carbon 
fixation but also increase agricultural yields. Towards this goal researchers have 
been able to form β-carboxysome like structures in Nicotiana benthamiana 
chloroplasts by expression of 3 proteins (CcmO-YFP, CcmK2 and CcmL-YFP or 
CcmM58-YFP), however it must be noted that similar structures are not seen in the 
absence of YFP fusions suggesting possible solubility issues [47]. 
 
Engineering BMC shells 
The size and charge of the pores observed in BMC shells dictate the molecules that 
can pass into and out of the organelle [27]. The repurposing of BMCs for 
biotechnological applications depends upon the ability to modify the substrate 
specificity of the shell. Recent work has shown that mutations to pore residues do 
indeed result in altered pore properties while still allowing for incorporation in both 
carboxysomes and Pdu metabolosomes [42]. Similarly, a trimeric BMC shell protein 
has recently been engineered to bind a [4Fe-4S] cluster in the pore allowing for the 
potential of passing or receiving electrons to or from a BMC [35]. The work to date 
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provides a foundation for the de-novo design of pores to facilitate the construction of 
internalised metabolic pathways. 
 
The high degree of structural and sequence similarity of BMC shell proteins has 
enabled the production of chimeric BMC shells, that offer the potential for bespoke 
functionality over their wildtype counterparts. Expression of the α-carboxysomal shell 
protein CsoS1 in a CcmK2 deletion mutant, unable to form β-carboxysomes, formed 
hybrid carboxysome shells [42]. Similarly, it has been shown that EutM is able to 
integrate into a PduA deletion mutant in S. enterica [48]. It has also been shown that 
expression of both the Pdu and Eut operons in S. enterica hybrid BMC shells were 
produced incorporating both Eut and Pdu shell proteins [49]. Overall, this suggests 
that shell proteins can easily be interchanged to allow for the development of BMCs 
with different permeability properties. 
 
Confirming the presence of assembled recombinant BMCs 
Wild-type BMCs have a number of defining characteristics when observed both in 
vivo and following purification by TEM and fluorescent microscopy techniques. In the 
case of fluorescent microscopy it has been shown that fluorescent proteins such as 
GFP can be fused to specific shell proteins, allowing the BMCs to be visualised as 
fluorescent puncta within the bacterial cytoplasm. However, the observation of 
fluorescent puncta within the cell can also be caused by aggregation of recombinant 
proteins and therefore BMCs should be confirmed through a combination of 
experimental approaches. We outline, in Textbox 1, a number of key characteristics 
that should be fulfilled in order for researchers to claim successful BMC formation. 
The criteria for confirmation of BMC formation should include an analysis by TEM to 
show the size of the organelle (50-200 nm in diameter), shape (polygonal, straight 
edges, angular facets) and number (from 5 to 50 per cell). Fluorescent microscopy 
can be used to show the presence of puncta within the cell and the targeting of cargo 
to the BMCs, and the purified BMCs should have a characteristic protein profile when 
analysed by SDS-PAGE. During recombinant production of BMCs some publications 
have claimed to show the presence of BMCs with structures that clearly do not fill 
these criteria, but more closely resemble protein aggregates or lipid vesicles. Such 
contaminants are likely due to the relatively crude purification methods used to 
extract BMCs. The most problematic are lipid vesicles, which are known to be of 
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approximately the same diameter as BMCs and are as such often mistaken for 
BMCs.  
 
Empty BMCs and their refunctioning 
The application of BMCs for commercial and industrial applications depends on the 
ability to not only redesign the properties of the outer shell, as discussed previously, 
but also on the ability to repurpose BMC shells and the encapsulation of new 
processes. Following the transfer of the entire Pdu operon from C. freundii and 
expression in E. coli it was shown that through the expression of a minimal set of 
proteins empty Pdu BMC shells could be produced opening up the possibility for the 
re-purposing of these bacterial organelles (Figure 3B) [44]. This process appears to 
work well with the Pdu system. Several attempts have been made to recombinantly 
produce Eut BMCs, however, the structures observed lack distinctive BMC features 
and more closely resemble lipid vesicles [40, 50, 51]. Recently it has been shown 
that through expression of the shell proteins of a BMC of unknown function from 
Haliangium ochraceum in E. coli regularly shaped BMCs can be visualised following 
purification (Figure 3C) [52]. Intriguingly, structures were not observed in vivo 
possibly due to a lack luminal electron density hindering visualisation, alternatively it 
may be that BMCs are forming during purification, as a result of an imbalance in 
protein stoichiometry in vivo. Nonetheless this BMC has been crystallised as 
discussed below [53] and provided fundamental insights into the structural 
arrangements of shell proteins within these remarkable macromolecular assemblies. 
 
A major goal in the utilisation of BMC technology is to be able to re-purpose these 
intracellular organelles to provide novel functionality. The first proof of concept study 
was conducted which showed that an ethanol bioreactor could be produced by 
tagging the enzymes pyruvate decarboxylase and alcohol dehydrogenase with EPs 
and their coproduction with the proteins required to form an empty BMC [39]. The 
resulting strains produced more ethanol in vivo in comparison to strains producing 
untagged enzymes with BMC shells.  
 
A similar attempt was made to engineer a bioreactor for 1,2-propanediol production 
utilising 4 enzymes and the same EPs [41]. However, in this case a 245% increase in 
1,2-propanediol production was observed irrespective of the presence of shell 
BMC Technology 
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proteins. TEM imaging revealed the presence of large intracellular inclusion bodies 
which are thought to increase local enzyme concentrations and provide an 
environment for substrate channelling.  
 
Bioremediation of industrial waste to remove metals and other toxic compounds has 
been of industrial interest for many years [54]. To this end BMCs have been thought 
of as potential facilitator of this due to their ability to sequester molecules from the 
cytoplasm enabling microorganisms to sequester greater levels of toxic molecules 
without impacting on their viability. Recently it has been shown that the expression of 
encapsulated polyphosphate kinase results in the build-up of polyphosphate that is 
not degraded by the expression of an exopolyphosphatase suggesting the protection 
of polyphosphate within the lumen of the BMC [55]. This initial investigation highlights 
the potential of BMCs to serve as an intracellular sink for toxic molecules. 
 
Structure of a recombinant BMC. 
The first crystal structures of individual BMC-H, BMC-T and BMC-P proteins allowed 
the generation of models for the outer shell of a BMC [27, 34]. More recently, a 
structure of a recombinant BMC, of unknown function, from Haliangium ochraceum 
has been resolved by cryo-electron microscopy and x-ray crystallography [53]. The 
40 nm diameter, single layer icosahedron is composed of 60 hexameric and 20 
trimeric shell proteins, with 12 pentameric tiles located at the vertices (Figure 3D). 
The structure reveals 4 distinct protein-protein interfaces; 2 hexamer-hexamer 
interactions, a hexamer-trimer interaction and a hexamer-pentamer interaction. The 
high degree of sequence and structural similarity means that these interactions are 
likely conserved across BMC systems [53]. 
 
Engineering BMC components 
To date major successes have been made through the deconstruction of BMC 
systems and the utilization of the component parts to form novel cytoplasmic 
architectures. Researchers initially observed filamentous structures when 
constructing systems for the expression of empty Pdu BMCs (Figure 4A) [44]. These 
filaments, around 20 nm in diameter, were found to be composed of the hexameric 
BMC building block PduA. It has been shown that it is possible to target fluorescent 
proteins to these bundles of filaments in vivo utilizing BMC targeting peptides [56]. A 
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PduA homologue RmmH from Mycobacterium smegmatis was similarly found to form 
nanotubes however in this case the structures observed had a diameter of ~ 14 nm 
(Figure 4B) [57]. Researchers have shown that mutations to residues at the 
hexamer-hexamer interface of PduA results in the formation of more sheet-like 
assemblies in vivo offering the opportunity to re-design a PduA based scaffold 
(Figure 4C) [58].  
 
Lately, a 3-component system has been developed comprising the hexameric BMC 
shell protein PduA and a pair of de-novo designed coiled-coils [59]. The resulting 
filamentous scaffold is arrayed throughout the bacterial cytoplasm rather than aligned 
as is the case with the unmodified variant (Figure 4D). By tagging fluorescent 
proteins with the cognate partner peptide such tagged proteins can be localised to 
the scaffold. Targeting the enzymes pyruvate decarboxylase and alcohol 
dehydrogenase to the scaffold resulted in a 221% increase in ethanol production as a 
result of the enhanced co-localisation of the enzymes. Additionally, it is possible to 
target this intracellular cytoscaffold to the inner membrane of the cell, a characteristic 
that may facilitate rapid channelling of intermediates between enzymes and due to 
the specific localisation of the scaffold/ enzyme complex faster export of products out 
of the cell.  
 
The same coiled-coil peptide system has also been used to target protein cargo to 
either the inside or outside of a recombinant BMC in vivo [60]. In this case, one of the 
coiled-coil peptides was attached to the N-terminus of PduA, which is located on the 
outer-facing (cytoplasmic) concave side of the protein. Attachment of the cognate 
coiled-coil peptide to a fluorescent cargo protein then directed the fluorophore to the 
outside of the BMC. The redesign of PduA from a BMC-HC to a permuted 
conformation BMC-HP then allows for the N-terminus to be located on the inside of 
the compartment, thereby allowing targeting of cargo to the interior [60]. A similar 
idea of using affinity handles and covalent linkages to target proteins to the lumen of 
recombinant BMCs has also been reported with the H. ochraceum system [61].  
 
Concluding remarks 
Since their first visualisation in the 1950s and subsequent rapid expansion in 
investigations over recent years, BMCs and related technologies have come to the 
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fore as a mechanism to enhance the spatial organisation of metabolic pathways. 
Significant work to date has focussed on not only understanding the characteristics of 
wild type organelles but also on the re-design of such systems to provide novel 
functionality. On-going work has shown that it is possible to produce BMCs in a 
recombinant and functional fashion and to direct new protein cargo to their lumen. 
Engineering different sized pores and the properties of the shell proteins all indicate 
that the redesign of BMCs for bespoke applications is a tangible, realistic and 
achievable challenge. The introduction of carboxysomes into plants is of great 
interest as it holds the potential to enhance crop yields and some initial steps have 
been taken towards this goal. Future efforts will undoubtedly expand on this early 
work. Similarly proof of concept studies have shown how recombinant BMCs can be 
utilised for the production of commodity chemicals and the sequestering of toxic 
compounds from the cellular cytoplasm. The development of shell proteins into 
cytoplasmic scaffolds and the use of EPs to promote shell-less aggregation highlight 
ways in which BMC technology is being harnessed for engineering purposes (Figure 
5). Such studies have shown the potential of BMC technology and provide a platform 
for its industrial application. Despite the wealth of knowledge that has been 
generated in the field a significant number of fundamental questions remain (see 
Outstanding Questions). Genomic analysis has revealed 23 BMC subtypes in a 
diverse variety of species, however, few have been experimentally characterised. 
Such uncharacterised systems may possess bespoke functionality, further our 
understanding of native systems and offer new opportunities for the reprograming of 
such organelles for synthetic biology applications.   
 
There also remain a number of outstanding general basic scientific questions 
concerning the appearance of BMCs, including how and why they evolved. BMCs 
represent one of the most complex proteinaceous structures within the bacterial cell 
and there is still much to learn not only about their assembly but also their dis-
assembly. Finally, metabolosomes, especially, represent unique multi-enzyme 
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Functional characteristics of wild-type BMCs. LHS cartoon representation of a 
bacterial cell containing BMCs. RHS pathways encapsulated within anabolic 
carboxysomes (top) and metabolic metabolosomes (bottom). Highlighting the toxic 
and volatile intermediates sequestered by each BMC in red. 
 
Figure 2 
Classification of BMC shell proteins and their suggested functions. 
 
Figure 3 
Recombinant production of BMCs: (A) Thin section of E. coli Recombinantly 
producing Pdu metabolosomes. Reproduced with permission from [32] (B) 
Micrograph of negative stained, empty, Pdu BMCs. (C) Synthetic construction of 
negatively stained empty, H. ochraceum BMCs of unknown function. Reproduced 
with permission from [52]  (D) Surface representation of the crystal structure of H. 
ochraceum BMC shown in C, BMC-H in blue, BMC-TD in green and BMC-P in yellow. 
Reproduced with permission from [53]  Scale bars in A and B, 200 nm, C, 50 nm 
 
Figure 4 
Recombinant production of hexameric BMC components in E. coli: (A) Thin section 
of E. coli expressing C. freundii, PduA*. Reproduced with permission from [59] (B) 
Purified, negative stained M. smegmatis, RmmH. Reproduced with permission from  
[57] (C) Thin section of C. freundii, R79A PduA* mutant recombinantly expressed in 
E. coli. Reproduced with permission from [58] (D) CC-Di-B tagged PduA* forming a 
filamentous cytoscaffold in E. coli. Reproduced with permission from [59]. Scale bars 
in A and C, 200 nm, in B, 100 nm and in D, 500 nm 
 
Figure 5 
BMC based architectures for enhancing the spatial organisation of metabolic 
pathways. LHS: Encapsulation of a metabolic pathway within a BMC by fusing 
enzymes to BMC encapsulation peptides. Middle: Arrangement of enzymes on a 
BMC shell protein based scaffold. RHS: Aggregation of a metabolic pathway into an 


























































¥ Bacterial microcompartments (BMCs) are widespread proteinaceous 
organelles consisting of a semipermeable protein shell and an encapsulated 
enzymatic pathway.  
¥ Can be divided into the anabolic carboxysomes and the catabolic 
metabolosomes. 
¥ Targeting to organelles is facilitated by short, amphipathic, alpha helical 
encapsulation peptides. 
¥ Heterologous enzymatic pathways can be encapsulated within empty 
organelles, resulting in enhanced productivity. 
¥ A BMC-H based cytoscaffold is able to significantly enhance biofuel 





















Outstanding Questions box 
 
¥ What determines the size of BMCs? Does the shell or the cargo dictate the 
size? 
¥ Do metabolosomes assemble by the same mechanism as the alpha or beta 
carboxysomes or by a third mechanism? 
¥ What do encapsulation peptides interact with and how are proteins 
encapsulated within BMCs? 
¥ Are some enzymes localised to the cytoplasmic surface of BMCs? 
¥ What is the function of the BMC shell proteins that are yet to be 
characterised? 
¥ How are large co-factors transported into BMCs? 


















Text box 1 
 
Production and characterisation of recombinant BMCs 
 
Key characteristics that should be fulfilled in order for researchers to claim successful 
observation of wild type and recombinant BMC formation: 
 
¥ Angular facets when observed by TEM both in-vivo and following purification 
(Figure IA and B) 
¥ Immuno gold labelling of structures (Figure IC) 
¥ Expected protein profile when analysed by SDS-PAGE (Figure ID) 
¥ In-vivo punctate fluorescence in fluorescently modified constructs, not polar 
aggregates (Figure IE) 
¥ Ability to target recombinant proteins to BMC structures by fusion to 




Figure I. Characteristics of recombinantly produced BMCs. (A) Thin section of E. coli 
cells recombinantly expressing empty Pdu BMCs (B) Purified, thin sectioned, empty 
Pdu BMCs. (C) Thin section of E. coli expressing empty Pdu BMCs cross-reacted 
with anti-PduA antibodies and then with a secondary antibody conjugated to 15 nm 
gold particles. Reproduced with permission from [44]. (D) SDS-PAGE analysis of 
purified BMCs in comparison to a molecular weight standard. Reproduced with 
permission from [44]. (E, F) Confocal microscopy of E. coli expressing mCherry 
labelled BMCs with D18 tagged Citrine, showing mCherry and Citrine fluorescence in 





Bacterial Microcompartment: proteinaceous organelles  ~ 100 nm in diameter 
found in ~ 20 % of bacterial species that encases either anabolic or catabolic 
processes. 
 
BMC-H: A component of the BMC shell containing a single Pfam 00936 domain, 6 
BMC-H proteins come together to form a homohexameric tile that forms part of the 
BMC shell. 
 
BMC-T: A component of the BMC shell containing two fused Pfam 00936 domains, 3 
BMC-T proteins come together to form a homotrimeric tile that forms part of the BMC 
shell. 
 
BMC-P: A component of the BMC shell containing a single Pfam 03319 domains, 5 
BMC-P proteins come together to form a homopentameric tile that forms the vertices 
of the BMC 
 
Carboxysome: A bacterial organelle containing the enzymes carbonic anhydrase to 
generate a high local concentration of CO2 and ribulose 1,5-bisphosphate 
carboxylase/oxygenase (RuBisCO) to catalyse the carboxylation of ribulose 1,5-
bisphosphate, the first step in carbon fixation. 
 
Encapsulation peptide: short (~18 amino acid) peptides that form amphipathic 
alpha helices natively found on the N- or C-terminus of encapsulated proteins that 
target such proteins to the lumen of BMCs. 
 
Metabolosome: catabolic BMCs that encase a metabolic pathway in which a 
signature enzyme converts a metabolite into an aldehyde which is subsequently 
converted into an acid and alcohol. 
 
Signature enzyme: A metabolosome enzyme that is specific to the first substrate to 
product conversion. 
 
 
 
